These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 22449377)
1. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production. Helmy MM; El-Gowelli HM Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377 [TBL] [Abstract][Full Text] [Related]
2. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745 [TBL] [Abstract][Full Text] [Related]
3. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892 [TBL] [Abstract][Full Text] [Related]
4. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977 [TBL] [Abstract][Full Text] [Related]
6. Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats. Ozkan E; Yardimci S; Dulundu E; Topaloğlu U; Sehirli O; Ercan F; Velioğlu-Oğünç A; Sener G J Surg Res; 2010 Mar; 159(1):588-94. PubMed ID: 19515388 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment with hydrogen-rich saline reduces the damage caused by glycerol-induced rhabdomyolysis and acute kidney injury in rats. Gu H; Yang M; Zhao X; Zhao B; Sun X; Gao X J Surg Res; 2014 May; 188(1):243-9. PubMed ID: 24495844 [TBL] [Abstract][Full Text] [Related]
9. Montelukast protects against renal ischemia/reperfusion injury in rats. Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888 [TBL] [Abstract][Full Text] [Related]
10. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of L-carnitine on myoglobinuric acute renal failure in rats. Aydogdu N; Atmaca G; Yalcin O; Taskiran R; Tastekin E; Kaymak K Clin Exp Pharmacol Physiol; 2006; 33(1-2):119-24. PubMed ID: 16445710 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Sener G; Sehirli O; Cetinel S; Ercan F; Yüksel M; Gedik N; Yeğen BC Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):453-62. PubMed ID: 16162403 [TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats. Al-Amran FG; Hadi NR; Hashim AM Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661 [TBL] [Abstract][Full Text] [Related]
14. Experimental myoglobinuric acute renal failure: the effect of vitamin C. Ustundag S; Yalcin O; Sen S; Cukur Z; Ciftci S; Demirkan B Ren Fail; 2008; 30(7):727-35. PubMed ID: 18704822 [TBL] [Abstract][Full Text] [Related]
15. Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines and Fas production. El-Gowilly SM; Helmy MM; El-Gowelli HM Vascul Pharmacol; 2015 Nov; 74():139-150. PubMed ID: 26163452 [TBL] [Abstract][Full Text] [Related]
16. The effects of montelukast against amikacin-induced acute renal damage. Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878 [TBL] [Abstract][Full Text] [Related]
17. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats. Saad MA; Abdelsalam RM; Kenawy SA; Attia AS Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620 [TBL] [Abstract][Full Text] [Related]
18. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. Abdel-Raheem IT; Khedr NF Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats. Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969 [TBL] [Abstract][Full Text] [Related]